We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+23.98%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$71.2B
AUM Growth
+$9.28B
(+15%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
36.79%
Holding
978
New
47
Increased
453
Reduced
412
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$319M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$92.7M |
| 5 |
UnitedHealth
UNH
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$182M |
| 2 |
RTX Corp
RTX
|
+$97.9M |
| 3 |
Marvell Technology
MRVL
|
+$81.2M |
| 4 |
GE Vernova
GEV
|
+$80.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
EPAM Systems
EPAM
$6.04B
| – | – |
-2,911
| Closed | -$394K |
|
952
Fulcrum Therapeutics
FULC
$294M
| – | – |
-2,211,953
| Closed | -$17M |
|
953
Guardant Health
GH
$21.7B
| – | – |
-90,124
| Closed | -$8.32M |
|
|
HOLX
954
DELISTED
Hologic
HOLX
| – | – |
-193,921
| Closed | -$14.7M |
|
|
955
Honeywell
HON
$66.4B
| – | – |
-805,664
| Closed | -$182M |
|
956
Immunocore
IMCR
$1.86B
| – | – |
-116,857
| Closed | -$3.52M |
|
957
iShares MSCI India ETF
INDA
$6.77B
| – | – |
-29,967
| Closed | -$1.4M |
|
958
Infosys
INFY
$47.4B
| – | – |
-62,410
| Closed | -$843K |
|
959
Iovance Biotherapeutics
IOVA
$3.98B
| – | – |
-155,000
| Closed | -$544K |
|
|
KW
960
DELISTED
Kennedy-Wilson Holdings
KW
| – | – |
-42,759
| Closed | -$463K |
|
961
Li Auto
LI
$12.1B
| – | – |
-42,936
| Closed | -$766K |
|
962
Match Group
MTCH
$9.61B
| – | – |
-10,056
| Closed | -$309K |
|
|
NUVL
963
DELISTED
Nuvalent
NUVL
| – | – |
-123,577
| Closed | -$12.7M |
|
964
Ocular Therapeutix
OCUL
$2.34B
| – | – |
-558,380
| Closed | -$4.73M |
|
965
Planet Fitness
PLNT
$3.84B
| – | – |
-98,533
| Closed | -$7.33M |
|
966
Pool Corp
POOL
$6.73B
| – | – |
-1,728
| Closed | -$350K |
|
967
Ultragenyx Pharmaceutical
RARE
$1.51B
| – | – |
-38,499
| Closed | -$807K |
|
|
SLNO
968
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-287,456
| Closed | -$9.62M |
|
969
Snap
SNAP
$9.25B
| – | – |
-11,328
| Closed | -$52.1K |
|
970
Suzano
SUZ
$11.3B
| – | – |
-158,033
| Closed | -$1.58M |
|
971
Trip.com Group
TCOM
$25.8B
| – | – |
-15,383
| Closed | -$766K |
|
972
TScan Therapeutics
TCRX
$26.5M
| – | – |
-918,020
| Closed | -$927K |
|
973
Twist Bioscience
TWST
$8.21B
| – | – |
-73,619
| Closed | -$3.5M |
|
|
VRE
974
DELISTED
Veris Residential
VRE
| – | – |
-26,533
| Closed | -$501K |
|
|
OKLO
975
Oklo
OKLO
$7.68B
| – | – |
-10,151
| Closed | -$503K |
|
Similar funds
Aberdeen Group's Q2 2026 Portfolio in Review
As of Q2 2026, Aberdeen Group held 978 positions worth $71.2B, up 15% from $61.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q2 2026 filing shows 47 new, 453 increased, 412 reduced and 44 closed positions. Its largest new stake was Honeywell Aerospace: 420,093 shares worth $92.9M. The largest sale was Honeywell, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q2 2026 buy was Honeywell Aerospace: 420,093 shares worth $92.9M.
- Aberdeen Group added most to Tesla in Q2 2026, an estimated $319M increase.
- Aberdeen Group's biggest Q2 2026 reduction was RTX Corp, cutting an estimated $97.9M.
- Aberdeen Group fully exited Honeywell in Q2 2026, selling an estimated $182M.
- Aberdeen Group's ten largest holdings make up 37% of its $71.2B portfolio in Q2 2026.
- Aberdeen Group opened 47 new positions and closed 44 in Q2 2026.
- Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $71.2B.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.